
IMMUNOHBs180 IU/ml
ZAS Corporation
Hepatitis b immune globulin is a passive immunizing agent used for post-exposure prophylaxis against hepatitis B virus (HBV) infection.
Hepatitis b immune globulin is a passive immunizing agent used for post-exposure prophylaxis against hepatitis B virus (HBV) infection. Its established and guideline-supported uses include:
Hepatitis b immune globulin provides passive, immediate but temporary protection; it does not treat an already-established hepatitis B infection and is not a substitute for hepatitis B vaccination, which should be given concurrently (at a separate site) whenever indicated for long-term active immunity.
Hepatitis b immune globulin must be administered by, or under the direct supervision of, a qualified healthcare professional in a clinical setting, by intramuscular or intravenous injection depending on the specific product and indication. It should be given as soon as possible after exposure, since efficacy declines with delay.
| Indication | Typical Dosing | Timing |
|---|---|---|
| Perinatal exposure (infant of HBsAg-positive mother) | Approximately 0.5 mL (per product labeling) intramuscularly, together with the first dose of hepatitis B vaccine at a separate injection site | Within 12 hours of birth |
| Percutaneous/mucosal exposure (e.g. needlestick) | Approximately 0.06 mL/kg body weight intramuscularly (per product labeling), with hepatitis B vaccine series if not previously vaccinated | As soon as possible, preferably within 24 hours and generally not later than 7 days after exposure |
| Sexual exposure to an infected partner | Approximately 0.06 mL/kg body weight intramuscularly (per product labeling) | Within 14 days of the most recent sexual contact |
| Prevention of HBV recurrence after liver transplantation | Product-specific intravenous dosing (often weight- or titer-based), used as part of a defined perioperative and long-term regimen with antiviral therapy | Perioperatively, then at intervals per transplant protocol |
Exact volume/dose depends on the specific licensed product; the prescribing healthcare professional determines the precise dose and schedule.
Most reactions to Hepatitis b immune globulin are mild and local. Reported side effects include:
As with all plasma-derived products, there is a theoretical risk of transmission of infectious agents, although this risk is minimized by donor screening and viral-inactivation steps used during manufacture. Any signs of a severe allergic reaction require immediate medical attention.
Hepatitis b immune globulin is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.